Header Logo

Connection

PADMANEE SHARMA to Prospective Studies

Back to Details
This is a "connection" page, showing publications PADMANEE SHARMA has written about Prospective Studies.
PADMANEE SHARMA
Connection Strength
0.041
Prospective Studies
  1. Rationale and Outcomes for Neoadjuvant Immunotherapy in Urothelial Carcinoma of the Bladder. Eur Urol Oncol. 2020 12; 3(6):728-738.
    View in: PubMed
    Score: 0.016
  2. Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study. J Clin Oncol. 2017 Dec 01; 35(34):3851-3858.
    View in: PubMed
    Score: 0.013
  3. Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study. Lancet Oncol. 2017 04; 18(4):446-453.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.